2-ethylthiophene | 6911-35-9

• 分子结构分类: 有机化合物 - 有机硫化合物 - 硫醚类
• 英文名称: 2-ethylthiophene
• 英文别名: 2-ethylsulfanyl-thiophene；2-Aethylmercapto-thiophen；2-(ethylsulfanyl)-thiophen；2-(ethylsulfanyl)thiophen；Thiophene, 2-ethylthio；2-ethylsulfanylthiophene
• CAS: 6911-35-9
• 化学式: C₆H₈S₂
• 分子量: 144.262
• InChiKey: XLEZAQDRMZZJTO-UHFFFAOYSA-N

物化性质

• 保留指数：
  1106;1091;1092;1096;1106;1110;1115

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  8
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  53.5
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  2-ethylthiophene 在 三氯氧磷 作用下， 生成 5-ethylmercapto-thiophene-2-carbaldehyde thiosemicarbazone
  参考文献：
  名称：

  Profft, Monatsberichte der Deutschen Akademie der Wissenschaften zu Berlin, 1959, vol. 1, p. 180,181

  摘要：

  DOI：
• 作为产物：
  描述：

  噻吩 在 正丁基锂 、 乙醚 作用下， 生成 2-ethylthiophene
  参考文献：
  名称：

  Gol'dfarb et al., Zhurnal Obshchei Khimii, 1959, vol. 29, p. 2034,2041; engl. Ausg. S. 2003, 2009

  摘要：

  DOI：

文献信息

• [EN] SMALL MOLECULE INHIBITORS OF LEMUR TYROSINE KINASE 3<br/>[FR] INHIBITEURS À PETITES MOLÉCULES DE LA LÉMUR TYROSINE KINASE 3
  申请人：UNIV SUSSEX

  公开号：WO2022053838A1

  公开（公告）日：2022-03-17

  The present invention relates to compounds of formula (I) and compositions comprising the same. The compounds and compositions may be used treat, prevent or ameliorate diseases treatable by inhibition of the Lemur tyrosine kinase 3 (LMTK3), such as cancer.

  本发明涉及公式（I）的化合物和包含该化合物的组合物。这些化合物和组合物可用于治疗、预防或改善通过抑制Lemur酪氨酸激酶3（LMTK3）可治疗的疾病，如癌症。
• IMIDAZO[1,2-a]PYRIDINE COMPOUNDS
  申请人：Fang Qun Kevin

  公开号：US20110166146A1

  公开（公告）日：2011-07-07

  Imidazo[1,2-a]pyridines are disclosed. Compounds of the invention are useful therapeutic agents and their inclusion in pharmaceutical formulations and use in methods of treatment are disclosed.

  本发明揭示了咪唑并[1,2-a]吡啶类化合物。该发明的化合物是有用的治疗剂，揭示了它们在制药配方中的包含以及在治疗方法中的使用。
• Process for production of N,N-disubstituted carboxylic acid amides
  申请人：TOKUYAMA SODA KABUSHIKI KAISHA

  公开号：EP0189774A1

  公开（公告）日：1986-08-06

  A novel process for producing N,N-disubstituted carboxylic acid amides represented by the following formula wherein R, R1, R2 and R3 are as defined in claim 1, which comprises contacting a Schiff base represented by the following formula (III) wherein R, R1 and R2 are as defined above, with a carboxylic acid derivative represented by the following formula (III) wherein R3 is as defined above, and M represents a halogen atom or the moiety in the presence of a silane compound represented by the following formula (IV) wherein X, Y and Z, independently from each other, represent a hydrogen atom or a halogen atom, in the presence or absence of an inert organic solvent.

  1.一种生产下式所代表的N，N-二取代羧酸酰胺的新工艺，其中R、R1、R2和R3如权利要求1所定义，该工艺包括在有或无惰性有机溶剂存在的情况下，将下式(III)所代表的希夫碱(其中R、R1和R2如上所定义)与下式(III)所代表的羧酸衍生物(其中R3如上所定义)和M代表卤素原子或分子在下式(IV)所代表的硅烷化合物(其中X、Y和Z各自代表氢原子或卤素原子)存在的情况下接触。
• Amide compounds
  申请人：TOKUYAMA SODA KABUSHIKI KAISHA

  公开号：EP0375387A2

  公开（公告）日：1990-06-27

  An amide compound represented by the following general formula (I) wherein R1 is a substituted or unsubstituted phenyl group, a substituted or unsubstituted furyl group, or a substituted or unsubstituted thienyl group; R2 is a halogen atom; R3 is a hydrogen atom, an alkyl group of 1-6 carbon atoms, or a halogen atom; R4 and R5 which may be the same or different, are a substituted or unsubstituted alkyl group of 1-12 carbon atoms, a substituted or unsubstituted alkenyl group of 2-12 carbon atoms, or a substituted or unsubstituted phenyl group: and an antimicrobial agent containing as an active ingredient the said amide compound.

  由以下通式(I)代表的酰胺化合物 其中 R1 是取代或未取代的苯基、取代或未取代的呋喃基或取代或未取代的噻吩基； R2 是卤素原子； R3 是氢原子、1-6 个碳原子的烷基或卤素原子； R4 和 R5 可以相同或不同，是 1-12 个碳原子的取代或未取代的烷基、2-12 个碳原子的取代或未取代的烯基或取代或未取代的苯基：以及含有上述酰胺化合物作为活性成分的抗菌剂。
• NITROGENOUS FUSED&minus;RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF
  申请人：Eisai Co., Ltd.

  公开号：EP1382603A1

  公开（公告）日：2004-01-21

  The present invention provides a compound having an excellent inhibitory action on activation of STAT6 and a pharmaceutical composition thereof. Inparticular, it provides a compound represented by the following formula (I), a salt thereof or a hydrate of them. In the formula, X represents a nitrogen-containing condensed aromatic heterocyclic group such as imidazo[1,2-a]pyridine, benzimidazole, quinazoline, quinoline, or 2,1-benzisoxazole and has (R4)n as substituent groups; Y represents a C3-8 cycloalkyl group, C4-8 cycloalkenyl group, 5- to 14-membered non-aromatic heterocyclic group, C6-14 aromatic hydrocarbon cyclic group or 5- to 14-membered aromatic heterocyclic group; n in (R4)n is 0, 1, 2 or 3, and Z groups independently represent (1) hydrogen atom, (2) amino group, (3) halogen atom, (4) hydroxyl group, (5) nitro group, (6) cyano group, (7) azido group, (8) formyl group, (9) hydroxyamino group, (10) sulfamoyl group, (11) guanodino group, (12) oxo group, (13) C2-6 alkenyl group, (14) C1-6 alkoxy group, (15) C1-6 alkylhydroxyamino group, (16) halogenated C1-6 alkyl group, (17) halogenated C2-6 alkenyl group, (18) (i) C3-7cycloalkyl group, (ii) C3-7cycloalkenyl group, (iii) 5- to 14-membered non-aromatic heterocyclic group, each of which may have one or more substituent groups Q, or (19) formula -M1-M2-M3, R1 represents (1) hydrogen atom, (2) halogen atom, (3) hydroxyl group, (4) nitro group, (5) cyano group, (6) halogenated C1-6 alkyl group, (7) C2-6 alkyl group substituted with a hydroxyl or cyano group, (8) C2-6 alkenyl group, or (9) formula -L1-L2-L3, and R2 represents a hydrogen atom or a protecting group; and R3 represents a hydrogen atom, halogen atom, cyano group, amino group, C1-4 alkyl group or halogenated C1-4 alkyl group.

  本发明提供了一种对 STAT6 的活化具有极佳抑制作用的化合物及其药物组合物。特别是提供了由下式（I）代表的化合物、其盐或它们的水合物。 式中，X代表含氮缩合芳香杂环基团，如咪唑并[1,2-a]吡啶、苯并咪唑、喹唑啉、喹啉或2,1-苯并异噁唑，并有(R4)n作为取代基；Y代表C3-8环烷基、C4-8环烯基、5～14元非芳香杂环基团、C6-14芳香烃环基或5～14元芳香杂环基团；(R4)n 中的 n 是 0、1、2 或 3，Z 基团独立地代表：(1) 氢原子，(2) 氨基，(3) 卤素原子，(4) 羟基，(5) 硝基，(6) 氰基，(7) 叠氮基，(8) 甲酰基，(9) 羟基氨基、(10) 氨基磺酰基，(11) 氨基胍基，(12) 氧代基，(13) C2-6 烯基，(14) C1-6 烷氧基，(15) C1-6 烷基羟基氨基，(16) 卤代 C1-6 烷基，(17) 卤代 C2-6 烯基，(18) (i) C3-7 环烷基、(ii) C3-7 环烯基，(iii) 5-14 元非芳杂环基团，其中每个基团可有一个或多个取代基 Q，或 (19) 式-M1-M2-M3，R1 代表 (1) 氢原子，(2) 卤素原子，(3) 羟基、(4) 硝基，(5) 氰基，(6) 卤代 C1-6 烷基，(7) 被羟基或氰基取代的 C2-6 烷基，(8) C2-6 烯基，或 (9) 式-L1-L2-L3，R2 代表氢原子或保护基团；R3 代表氢原子、卤素原子、氰基、氨基、C1-4 烷基或卤代 C1-4 烷基。